| |
| |
|
| Insider
Information: |
Lapalme Pierre |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
49,333 |
|
|
Indirect Shares
|
2,500 |
|
|
| Direct
Value |
$2,770,447 |
|
|
|
Indirect Value
|
$132,987 |
|
|
| Total
Shares |
51,833 |
|
|
| Total
Value |
$2,903,434 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2015-06-10 |
31,250 |
2015-06-10 |
1,500 |
Premium* |
|
|
Insys Therapeutics, Inc. |
INSY |
Director |
2019-03-04 |
18,083 |
2019-03-04 |
1,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
33 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2013-05-24 |
4 |
B |
$10.39 |
$10,395 |
I/I |
1,000 |
1,000 |
2.1 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2014-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,100 |
30,150 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2015-03-03 |
4 |
S |
$106.57 |
$2,131,400 |
D/D |
(20,000) |
30,150 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2015-03-03 |
4 |
OE |
$11.15 |
$284,800 |
D/D |
20,000 |
50,150 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2015-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,100 |
31,250 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2018-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
6,000 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2018-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
10,000 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2019-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
8,083 |
18,083 |
0 |
- |
|
33 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
